EUVIMEDEUVIMED entdecken
Open Access

Daidzein Mitigates Nicotine‐Induced Atherogenesis via Nrf2/ROS/TXNIP‐Dependent Inhibition of Macrophage Pyroptosis and Lipid Accumulation

Xiao-Dan Xu iD, Kun Ren, Xian Liu, Hui-Hui Wang, Xin-Yu Lan, Lin Zhu, Meng-Qing Ma, Wen-Wu Luo

Molecular Nutrition & Food Research · 2026-08 · 70 (15)

DOI: 10.1002/mnfr.70570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 09.08.2026. Verfasst von Xiao-Dan Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Atherosclerosis, Isoflavones, Nicotine. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the National Natural Science Foundation of China, the Natural Science Foundation of the Anhui Higher Education Institutions, the exceptional support plan of high-level talent introduction of Anhui University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Food‐derived bioactive components play a crucial role in the prevention of cardiovascular diseases. Daidzein (DAI), a soy isoflavone, possesses notable cardioprotective potential; however, its precise role in nicotine‐induced atherosclerosis (AS) and its underlying mechanisms remain unclear. This study explored whether DAI protects against AS by modulating macrophage pyroptosis and lipid metabolism via redox‐sensitive signaling pathways. In human acute monocytic leukemia cell line (THP‐1)‐derived macrophages, DAI alleviated nicotine‐induced pyroptosis, as evidenced by the downregulation of NOD‐like receptor family pyrin domain‐containing 3 (NLRP3), ASC, cleaved caspase‐1, and gasdermin D (GSDMD)‐N, accompanied by reduced secretion of interleukin (IL)‐1β, IL‐6, and IL‐18, and decreased lactate dehydrogenase (LDH) release and caspase‐1 activity. DAI also enhanced (7‐nitrobenz‐2‐oxa‐1,3‐diazole)‐cholesterol (NBD)‐cholesterol efflux, suppressed DiI‐labeled oxidized low‐density lipoprotein (DiI‐ox‐LDL) uptake, and mitigated intracellular lipid droplet accumulation. Mechanistically, silencing nuclear factor erythroid 2–related factor 2 (Nrf2), inducing reactive oxygen species (ROS), or overexpressing thioredoxin‐interacting protein (TXNIP) abolished the protective effects of DAI, confirming the involvement of the Nrf2/ROS/TXNIP pathway. In nicotine‐exposed apolipoprotein E‐deficient (apoE −/− ) mice, DAI upregulated vascular Nrf2, downregulated TXNIP and pyroptosis‐related proteins, improved plasma lipid profiles, alleviated systemic inflammation, and reduced aortic plaque formation, with no obvious adverse effects observed under the experimental conditions used. Collectively, DAI attenuated macrophage pyroptosis and lipid accumulation via the Nrf2/ROS/TXNIP pathway, thereby mitigating nicotine‐induced atherogenesis. These findings provide preclinical evidence for the potential of DAI as a food‐derived bioactive compound for smoking‐related AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2AtherosclerosisIsoflavonesNicotinePyroptosisMacrophagesLipid MetabolismCarrier ProteinsAnimalsHumansReactive Oxygen SpeciesMiceMice, Inbred C57BLMaleSignal Transduction

Stichwörter der Autor:innen

Nrf2/ROS/TXNIP signalingatherosclerosisdaidzeinlipid accumulationmacrophage pyroptosis

Substanzen

NF-E2-Related Factor 2IsoflavonesNicotineReactive Oxygen SpeciesdaidzeinCarrier ProteinsTXNIP protein, humanNFE2L2 protein, humanNfe2l2 protein, mouse

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China.
  • College of Nursing, Anhui University of Chinese Medicine, Hefei, Anhui, PR China.
  • Key Laboratory of Geriatric Nursing and Health, Anhui University of Chinese Medicine, Hefei, Anhui, PR China.
  • College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui, PR China.
  • Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China.

ORCID-Profile: Xiao-Dan Xu

Förderung

  • the National Natural Science Foundation of China
  • the Natural Science Foundation of the Anhui Higher Education Institutions
  • the exceptional support plan of high-level talent introduction of Anhui University of Chinese Medicine
  • the Project of Key Laboratory of Geriatric Nursing and Health of Anhui University of Chinese Medicine

Zitieren

APA

Xu, X. D., Ren, K., Liu, X., Wang, H. H., Lan, X. Y., Zhu, L., Ma, M. Q., & Luo, W. W. (2026). Daidzein Mitigates Nicotine‐Induced Atherogenesis via Nrf2/ROS/TXNIP‐Dependent Inhibition of Macrophage Pyroptosis and Lipid Accumulation. Molecular Nutrition & Food Research, 70(15). https://doi.org/10.1002/mnfr.70570

Vancouver

Xu XD, Ren K, Liu X, Wang HH, Lan XY, Zhu L, et al. Daidzein Mitigates Nicotine‐Induced Atherogenesis via Nrf2/ROS/TXNIP‐Dependent Inhibition of Macrophage Pyroptosis and Lipid Accumulation. Molecular Nutrition & Food Research. 2026;70(15). doi:10.1002/mnfr.70570

BibTeX
@article{Xu2026,
  author = {Xu, Xiao-Dan and Ren, Kun and Liu, Xian and Wang, Hui-Hui and Lan, Xin-Yu and Zhu, Lin and Ma, Meng-Qing and Luo, Wen-Wu},
  title = {Daidzein Mitigates Nicotine‐Induced Atherogenesis via Nrf2/ROS/TXNIP‐Dependent Inhibition of Macrophage Pyroptosis and Lipid Accumulation},
  journal = {Molecular Nutrition & Food Research},
  year = {2026},
  volume = {70},
  number = {15},
  doi = {10.1002/mnfr.70570}
}
Kostenlos starten →